HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Cibc World Markets Corp

Cibc World Markets Corp grew its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 13.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 29,268 shares of the company’s stock after acquiring an additional 3,383 shares during the quarter. Cibc World Markets Corp’s holdings in HCA Healthcare were worth $8,785,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. FMR LLC raised its holdings in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock valued at $1,276,909,000 after buying an additional 2,397,883 shares during the last quarter. Principal Financial Group Inc. raised its position in shares of HCA Healthcare by 120.1% during the 4th quarter. Principal Financial Group Inc. now owns 873,775 shares of the company’s stock worth $262,264,000 after buying an additional 476,756 shares in the last quarter. Meritage Group LP acquired a new position in shares of HCA Healthcare during the third quarter valued at approximately $150,548,000. Raymond James Financial Inc. acquired a new stake in HCA Healthcare in the fourth quarter worth approximately $74,121,000. Finally, Canoe Financial LP increased its stake in HCA Healthcare by 226,952.9% in the 4th quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after purchasing an additional 231,492 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on the stock. Wells Fargo & Company lowered shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Raymond James downgraded HCA Healthcare from an “outperform” rating to a “market perform” rating in a report on Friday, November 22nd. Royal Bank of Canada dropped their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research note on Monday, January 27th. Bank of America lowered their price target on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. Finally, KeyCorp reduced their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $385.67.

Insider Buying and Selling

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the transaction, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.60% of the stock is owned by company insiders.

HCA Healthcare Price Performance

NYSE HCA opened at $329.97 on Wednesday. The company has a market cap of $81.24 billion, a P/E ratio of 15.02, a P/E/G ratio of 1.10 and a beta of 1.68. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $417.14. The company has a fifty day simple moving average of $320.07 and a 200 day simple moving average of $344.03.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the firm earned $5.90 earnings per share. On average, sell-side analysts predict that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.